Am Soc Nephrol --Nov: 1995

Selected Abstracts

Clinical Nephrology

Reduced circulatory volume/sepsis/hepatorenal

c Is the administration of dopamine associated with adverse outcomes in acute renal failure?
c The role of loop diuretics in acute renal failure? A double- blind, randomised controlled trial

Cyclosporine, ARF in transplant patients

c Thyroid hormone for treatment of acute tubular necrosis in renal allografts: a prospective, randomized trial

Embolic disease

c Focal segmental glomerulosclerosis due to cholesterol atheroembolic disease: Clinicopathologic correlations

Acute glomerulonephritis/RPGN

c Effect of initial histology and plasmapheresis treatment on prognosis in RPGN: results of the German prospective randomized multicenter study
c Superantigen-related glomerulonephritis and vasculitis due to MRSA infection

Acute interstitial nephritis/NSAID

c Renal gallium scintigraphy helps decision-making in acute renal failure

Radiocontrast media

c Effect of hemodialysis after contrast media application in adults with renal insufficiency

Post surgical

c Acute renal failure following cardiac surgery

Urinary tract obstruction

c Distinctive effects between obstructive and non-obstructive pyelocaliectasis by duplex-Doppler ultrasonography

Infections (other than hepatitis, peritonitis)

c Outcome of HIV-infected patients on hemodialysis

Hereditary polycystic disease

c Autosomal dominant polycystic kidney disease patients are at risk for recurrent intracranial aneurysms
c Rate of loss of renal function in hypertensive and normotensive autosomal dominant polycystic kidney disease patients


c Trimethoprim/sulfamethoxazole in standard dose causes hyperkalemia
c Hyporeninemia is associated with erythropoietin deficiency in type I diabetic patients
c Examination for the thiazide-sensitive Na-Cl cotransporter as a candidate gene in Gordon's syndrome

Renal biopsy techniques, tips, complications

c Bleeding time does not predict bleeding complications post renal biopsy
c Timing of complications in percutaneous renal biopsy: what is the optimal period of observation?


c Effect of nondihydropyridine calcium antagonists on progression of nephropathy from non-insulin dependent diabetics: a five year follow-up study
c The ACE gene polymorphism in patients with diabetic nephropathy
c Short-term comparison of ACE inhibition vs. calcium channel blockade in African Americans with type II diabetic nephropathy
c Long-term effect of captopril on kidney function in normotensive insulin-dependent diabetic patients with diabetic nephropathy
c Correlates of diabetic and non-diabetic renal disease in NIDDM
c Smoking -- a major predictor of nephropathy in newly diagnosed type II diabetes
c Kidney/pancreas transplant versus kidney transplant alone
c Efficacy of captopril in normotensive diabetic patients with microalbuminuria - 8 years follow up
c Progression of overt diabetic nephropathy: Role of metabolic control
c Glomerular structure in long term type II diabetes with and without microalbuminuria
c Cyclosporine nephrotoxicity in insulin-dependent diabetic patients: an eight year follow up
c Renal production of TGF-beta is increased in diabetic patients
c Progression of diabetic nephropathy and the insertion/deletion polymorphismof the ACE gene

Focal, collapsing, fibrillary GN

c The impact of plasmapheresis on recurrent focal glomerular sclerosis in renal allografts
c Results of a 6 month randomized control trial of cyclosporine versus placebo in adults with steroid-resistant, idiopathic, focal segmental glomerulosclerosis
c Glomerular number in focal segmental glomerulosclerosis and minimal change nephrotic syndrome

IgA Nephropathy

c The deletion polymorphism in the ACE gene is a risk factor for the progression to renal failure independent of the M235T polymorphism in the angiotensinogen gene
c A family history of hypertension is associated to nephrosclerosis and predicts the future onset of hypertension in patients with IgA nephropathy

Hepatitis-associated nephropathy

c Infection with hepatitis C virus increases the risk of de novo glomerulonephritis in renal transplant recipients
c Serological and virological profiles in renal transplant candidates
c Liver histology in renal transplant patients after more than 10 years of HCV infection
c Localization of HCV in renal tissue of HCV-infected patients with cryoglobulinemic mesangiocapillary glomerulonephritis: an immuno- histochemical study
c Glomerular disease in HIV-infected patients with hepatitis C virus

HIV-associated nephropathy

c Clinicopathologic evaluation of prednisone treatment or patients with HIV nephropathy
c Response to early and prolonged inhibition of angiotensin converting enzyme in HIV-associated nephropathy
c HIV/AIDS as a cause of renal failure
c Contribution of globulins to plasma oncotic pressure and the presence of edema in HIV patients with proteinuria
c Cryoglobulinemia in HIV-infected patients with renal disease
c Captopril increases renal survival in patients with HIV nephropathy
c Absence of edema in HIV-infected patients with ESRD
c Prednisone ameliorates the progression on HIV-associated nephropathy
c Decreasing incidence of severe acute renal failure in patients with HIV infection
c Renal disease prevalence and risk factors among HIV-infected inner city residents
c Are we missing an epidemic of HIV-associated nephropathy?

Lupus nephritis

c Renal lesions in drug induced lupus syndromes

Membranous GN

c Changing incidence of idiopathic glomerular diseases in adults
c Therapy of membranous glomerulonephritis with nephrotic syndrome. Five year follow-up of a prospective, randomized study
c Urinary C5b-9 in early and advanced renal insufficiency in membranous nephropathy

Vasculitis (Wegener's PAN, etc.)

c Assessing the severity of renal disease in systemic vasculitis: how to the histopathologic data predict renal outcome?
c Prevention of relapses in systemic vasculitis
c ANCA-associated vasculitis and renal involvement: preliminary results of a prospective randomized study comparing daily oral versus monthly I.V. cyclophosphamide application
c Humanized monoclonal antibody therapy for Wegener's granulomatosis
c Prevention of relapses of Wegener's granulomatosis by treatment with co-trimoxazole. A placebo controlled trial.
c Outcome of children with ANCA positive glomerulonephritis

Renal Stones: Diagnosis

c Primary hyperoxaluria types I and II: clinical and lithogenic features

Renal Stones: Etiology

c Decreased bone formation in idiopathic hypercalciuric calcium stone formers explains reduced bone density
c A prospective study of dietary and supplemental calcium and the risk of kidney stones in women

UP Use back arrow on your browser to go back to HDCN home page (faster) or click on the arrow.